MANUEL
GOROSTIDI PEREZ
Profesor Asociado en CC. Salud - LOSU
University of Erlangen-Nuremberg
Erlangen, AlemaniaPublicaciones en colaboración con investigadores/as de University of Erlangen-Nuremberg (2)
2009
-
Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: Sub-analysis of a 52-week, randomized, double-blind trial
Journal of Hypertension, Vol. 27, Núm. 7, pp. 1493-1501
-
Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren. A 12-month randomized, double-blind comparator trial with hydrochlorothiazide
Circulation, Vol. 119, Núm. 3, pp. 417-425